| Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 inhibit splicing to human papillomavirus 16 splice site SA409 through a UAG-containing sequence in the E7 … Y Zheng, J Jönsson, C Hao, S Shoja Chaghervand, X Cui, N Kajitani, ... Journal of Virology 94 (20), 10.1128/jvi. 01509-20, 2020 | 26 | 2020 |
| Migratory refueling affects non-enzymatic antioxidant capacity, but does not increase lipid peroxidation C Eikenaar, J Jönsson, A Fritzsch, HL Wang, C Isaksson Physiology & Behavior 158, 26-32, 2016 | 26 | 2016 |
| hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs C Hao, Y Zheng, J Jönsson, X Cui, H Yu, C Wu, N Kajitani, S Schwartz Nucleic Acids Research 50 (7), 3867-3891, 2022 | 16 | 2022 |
| Identification of heterogenous nuclear ribonucleoproteins (hnRNPs) and serine-and arginine-rich (SR) proteins that induce human papillomavirus type 16 late gene expression and … C Hao, L Gong, X Cui, J Jönsson, Y Zheng, C Wu, N Kajitani, S Schwartz Archives of Virology 167 (2), 563-570, 2022 | 6 | 2022 |
| A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization J Jönsson, L Wang, N Kajitani, S Schwartz Nucleic Acids Research 52 (1), 316-336, 2024 | 4 | 2024 |
| The balance of splicing: A novel insight into the splicing regulation of high-risk HPV E6 and E7 oncogenes. J Jönsson Acta Universitatis Upsaliensis, 2023 | | 2023 |
